Listed

Xtant Medical Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2021

Filed with the SEC on Nov 12, 2021 and accepted by EDGAR at Nov 12, 2021, 07:30 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-07-01 to 2021-09-30$13.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2021-01-01 to 2021-09-30$41.3mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-07-01 to 2021-09-30$6.6mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2021-01-01 to 2021-09-30$16.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-07-01 to 2021-09-30$7.2mus-gaap:GrossProfit
Gross profit9 months2021-01-01 to 2021-09-30$24.8mus-gaap:GrossProfit
Research and development3 months2021-07-01 to 2021-09-30$262.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2021-01-01 to 2021-09-30$719.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-07-01 to 2021-09-30−$1.4mus-gaap:OperatingIncomeLoss
Operating income9 months2021-01-01 to 2021-09-30−$1.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-07-01 to 2021-09-30$329.0kus-gaap:InterestExpense
Interest expense9 months2021-01-01 to 2021-09-30$529.0kus-gaap:InterestExpense
Income tax3 months2021-07-01 to 2021-09-30$30.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2021-01-01 to 2021-09-30$94.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-07-01 to 2021-09-30−$1.8mus-gaap:NetIncomeLoss
Net income9 months2021-01-01 to 2021-09-30−$2.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-07-01 to 2021-09-30−$0.02us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2021-01-01 to 2021-09-30−$0.03us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-07-01 to 2021-09-30−$0.02us-gaap:EarningsPerShareBasic
Basic EPS9 months2021-01-01 to 2021-09-30−$0.03us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-07-01 to 2021-09-3086,763,210 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2021-01-01 to 2021-09-3084,926,656 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2021-01-01 to 2021-09-30$16.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2021-01-01 to 2021-09-30$1.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-09-30$18.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-09-30$45.6mus-gaap:AssetsCurrent
Total assetsAt period end2021-09-30$55.8mus-gaap:Assets
Current liabilitiesAt period end2021-09-30$10.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-09-30$23.2mus-gaap:Liabilities
Long-term debtAt period end2021-09-30$11.7mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2021-09-30$32.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-21-028011. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.